CompletedNot Applicable

Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls

United States49 participantsStarted 2006-11

Plain-language summary

Progression of nuclear sclerotic cataract after pars plana vitrectomy has been recognized for many years The mechanism for the rapid progression of nuclear sclerotic cataract remains unclear. The objective of this trial is to evaluate and compare the level and progression of cataract advancement in controls versus eyes that have undergone 20-gauge pars plana vitrectomy and 25-gauge pars plana vitrectomy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * phakic eyes of patients that are scheduled to undergo pars plana vitrectomy, * controls will be phakic eyes of patients that have not undergone andy kind of intraocular surgery, * age 18 and older Exclusion Criteria: * any eye that is pseudophakic, * has had previous vitreoretinal surgery, * has had previous intravitreal injection, * previous intraocular inflammatory condition such as uveitis, * previous irradiation, * any patient with a history of ocular malignancy, * history of infectious intraocular condition

Trial details

NCT IDNCT00406263

SponsorBarnes Retina Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-10

View on ClinicalTrials.gov More Nuclear Sclerotic Cataract trials